Cargando…

B-lymphocytes from melanoma patients and normal individuals react with melanoma cells but also with irrelevant antigens.

Peripheral B-lymphocytes of 13 patients with uveal melanoma and of 5 healthy individuals were transformed with Epstein-Barr virus (EBV). The reactivity of these transformed cells with autologous or allogeneic melanoma cells and lymphocytes was measured by the enzyme-linked immunosorbent assay (ELISA...

Descripción completa

Detalles Bibliográficos
Autores principales: Damato, B. E., Campbell, A. M., McGuire, B. J., Lee, W. R., Foulds, W. S.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1988
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246765/
https://www.ncbi.nlm.nih.gov/pubmed/3262365
_version_ 1782150837022228480
author Damato, B. E.
Campbell, A. M.
McGuire, B. J.
Lee, W. R.
Foulds, W. S.
author_facet Damato, B. E.
Campbell, A. M.
McGuire, B. J.
Lee, W. R.
Foulds, W. S.
author_sort Damato, B. E.
collection PubMed
description Peripheral B-lymphocytes of 13 patients with uveal melanoma and of 5 healthy individuals were transformed with Epstein-Barr virus (EBV). The reactivity of these transformed cells with autologous or allogeneic melanoma cells and lymphocytes was measured by the enzyme-linked immunosorbent assay (ELISA). Antigens which are neither self nor common environmental antigens (i.e., plant protoplasts, schistosome antigen and keyhole limpet haemocyanin) were used for controls. Lymphocyte reactivity with all types of antigen was apparent both in patients with uveal melanoma and in normal controls. The response detected by the techniques available is likely to reflect antibody multispecificity leading to mis-identification of irrelevant antigens.
format Text
id pubmed-2246765
institution National Center for Biotechnology Information
language English
publishDate 1988
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-22467652009-09-10 B-lymphocytes from melanoma patients and normal individuals react with melanoma cells but also with irrelevant antigens. Damato, B. E. Campbell, A. M. McGuire, B. J. Lee, W. R. Foulds, W. S. Br J Cancer Research Article Peripheral B-lymphocytes of 13 patients with uveal melanoma and of 5 healthy individuals were transformed with Epstein-Barr virus (EBV). The reactivity of these transformed cells with autologous or allogeneic melanoma cells and lymphocytes was measured by the enzyme-linked immunosorbent assay (ELISA). Antigens which are neither self nor common environmental antigens (i.e., plant protoplasts, schistosome antigen and keyhole limpet haemocyanin) were used for controls. Lymphocyte reactivity with all types of antigen was apparent both in patients with uveal melanoma and in normal controls. The response detected by the techniques available is likely to reflect antibody multispecificity leading to mis-identification of irrelevant antigens. Nature Publishing Group 1988-08 /pmc/articles/PMC2246765/ /pubmed/3262365 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Damato, B. E.
Campbell, A. M.
McGuire, B. J.
Lee, W. R.
Foulds, W. S.
B-lymphocytes from melanoma patients and normal individuals react with melanoma cells but also with irrelevant antigens.
title B-lymphocytes from melanoma patients and normal individuals react with melanoma cells but also with irrelevant antigens.
title_full B-lymphocytes from melanoma patients and normal individuals react with melanoma cells but also with irrelevant antigens.
title_fullStr B-lymphocytes from melanoma patients and normal individuals react with melanoma cells but also with irrelevant antigens.
title_full_unstemmed B-lymphocytes from melanoma patients and normal individuals react with melanoma cells but also with irrelevant antigens.
title_short B-lymphocytes from melanoma patients and normal individuals react with melanoma cells but also with irrelevant antigens.
title_sort b-lymphocytes from melanoma patients and normal individuals react with melanoma cells but also with irrelevant antigens.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246765/
https://www.ncbi.nlm.nih.gov/pubmed/3262365
work_keys_str_mv AT damatobe blymphocytesfrommelanomapatientsandnormalindividualsreactwithmelanomacellsbutalsowithirrelevantantigens
AT campbellam blymphocytesfrommelanomapatientsandnormalindividualsreactwithmelanomacellsbutalsowithirrelevantantigens
AT mcguirebj blymphocytesfrommelanomapatientsandnormalindividualsreactwithmelanomacellsbutalsowithirrelevantantigens
AT leewr blymphocytesfrommelanomapatientsandnormalindividualsreactwithmelanomacellsbutalsowithirrelevantantigens
AT fouldsws blymphocytesfrommelanomapatientsandnormalindividualsreactwithmelanomacellsbutalsowithirrelevantantigens